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Abstract
Since 2007, mortality associated with a previously unreported haemorrhagic disease has
been observed in young calves in several European countries. The syndrome, which has
been named ‘bovine neonatal pancytopenia’ (BNP), is characterised by thrombocytopenia,
leukocytopenia and a panmyelophthisis. A herd-level case-control study was conducted in
four BNP affected countries (Belgium, France, Germany and the Netherlands) to identify
herd management risk factors for BNP occurrence. Data were collected using structured
face-to-face and telephone interviews of farm managers and their local veterinarians. In
total, 363 case farms and 887 control farms were included in a matched multivariable condi-
tional logistic regression analysis. Case-control status was strongly associated with the
odds of herd level use of the vaccine PregSure® BVD (PregSure, Pfizer Animal Health)
(matched adjusted odds ratio (OR) 107.2; 95% CI: 41.0–280.1). This was also the case for
the practices of feeding calves colostrum from the calf’s own dam (OR 2.0; 95% CI: 1.1–3.4)
or feeding pooled colostrum (OR 4.1; 95% CI: 1.9–8.8). Given that the study had relatively
high statistical power and represented a variety of cattle production and husbandry systems,
it can be concluded with some confidence that no other herd level management factors are
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competent causes for a sufficient cause of BNP occurrence on herd level. It is suggested
that genetic characteristics of the dams and BNP calves should be the focus of further inves-
tigations aimed at identifying the currently missing component causes that together with
PregSure vaccination and colostrum feeding represent a sufficient cause for occurrence of
BNP in calves.
Introduction
Until 2007, only sporadic cases of haemorrhagic disease in young calves had been observed.
Starting that year, an increased number of young calves with haemorrhagic disease of
unknown origin in dairy and beef herds were reported. The first cases of the syndrome, later
named bovine neonatal pancytopenia (BNP), were reported in Bavaria in 2007, then in other
parts of Germany and in other European countries [1] such as the Netherlands [2], Belgium
[3], France [4], Great Britain [5], Italy [6], Ireland [7], Poland [8], Spain [9] and Hungary [10].
In 2011, the first cases of BNP were observed in New Zealand [11]. The total number of cases
reported in all of the affected European countries (around 6000 cases until 2014) suggests that
the disease is rare considering the large number of calf births [12].
Calves with BNP are aged 1 to 4 weeks when showing clinical signs of a haemorrhagic
diathesis [13, 14]. Cases are characterised by leukocytopenia and thrombocytopenia, regardless
of different thresholds used to define this disorder in different countries [13, 14]. The main
pathological sign is a trilineage depletion of stem cells in the bone marrow (panmyelophthisis)
in sternum or femur [13–15].
Early research into BNP examined different potential causes of haemorrhagic diathesis,
such as various poisons and infections including BVDV (bovine virus diarrhoea virus), BTV
(bluetongue virus), EHD (epizootic haemorrhagic disease), but diagnostic test results were all
negative [13–16]. As the disease occurs in both sexes and in different breeds it was considered
unlikely that a genetic factor would be the sufficient cause. However, a genetic predisposition
was hypothesised, because of the sporadic pattern of the disease within herds [13].
Investigations of risk factors for BNP revealed an association between the development of
BNP in calves and vaccination of their dams against BVD using PregSure1 BVD (PregSure,
Pfizer Animal Health) [3, 17–19]. However, these were relatively small-scale studies, and they
therefore did not have sufficient statistical power to detect additional risk factors with small
effect sizes. Other research into the aetiology of BNP suggested an autoimmune-mediated pro-
cess, whereby alloantibodies are transferred from the cow to the calf via the colostrum. The
involvement of colostrum as one mechanism for inducing the disease was demonstrated in
two experimental feeding trials. In these studies, feeding colostrum from cows that previously
had a calf with BNP to calves from other dams, which never had BNP-calves, resulted in BNP,
suggesting an autoimmune-mediated process [1, 20].
Bridger et al. and Pardon et al. [21, 22] identified alloreactive antibodies in the sera of BNP-
dams that bind to surface antigens on leucocytes of calves. Experimental immunisation of
cows showed that different vaccination schemes have an effect on the level of antibody titres,
increasing antibody titres to different degrees, and in turn affecting disease occurrence [23].
Although the association between vaccination of dams with PregSure and the occurrence of
BNP was assumed early in the process, the small number of cases in relation to the high num-
ber of vaccinated cows suggested that other factors were contributing to the aetiology.
Herd-level risk factors BNP in a multi-country study
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In a previously published study we explored animal-level risk factors for developing BNP
[24]. Vaccination of the calf’s dam with PregSure was the only risk factor strongly associated
with disease occurrence. It remains unknown what other factor(s) (or component causes) are
required to constitute a sufficient cause for this disease, considering the widespread use of the
vaccine (and feeding of colostrum from vaccinated dams) had still only resulted in a very low
BNP incidence. Therefore, the aim of this case-control study was to identify herd-level man-
agement factors associated with the occurrence of BNP in a large sample of farms from four
affected countries representing a variety of cattle production systems and husbandry condi-
tions in Europe, including a variety of management factors which had not been included in
previous studies, such as other vaccinations or routine treatments.
Materials and methods
Ethics statement
The research reported here does not involve data on human participants themselves, only on
farm management practices they were using. All data were collected via questionnaires. All
livestock owners were approached by their farm veterinarians, informed about the aim of the
study and asked if they were willing to participate, thereby asking for their verbal consent.
Questionnaires were only used with farmers who gave their verbal consent, which was noted
on the questionnaire. Data being entered into the online database were anonymized by using
the country code and the name of the veterinarian who provided the contact (in order to
match the farms on veterinary practice). No names of farmers were recorded in the database.
Livestock owners provided verbal consent for sampling their animals. Procedures on animals
used in the calf-level study were in accordance with the ethical conditions for animal experi-
mentation as mentioned in the European legislation (Directive 86/609/EEC). The blood sam-
ples collected from calves on the farms were taken for diagnostic purposes at the request of the
owners as part of clinical veterinary practice. The samples were taken by the animal owners’
veterinarians; in the Netherlands and Belgium by project veterinarians on behalf of the owners’
veterinarians. Ethics approval for sampling of the animals in this study was not required for
taking blood because this was done for diagnostic purposes by the animal owners’ veterinari-
ans. This is consistent with Animal Welfare legislation in the four study countries (Belgium,
France, Germany and the Netherlands).
Study design
A case-control study was conducted that recruited BNP-affected farms (cases) from four coun-
tries: Belgium, France, Germany and the Netherlands—all countries with comparatively high
BNP occurrence until mid-2010. The study was coordinated by staff from the Royal Veterinary
College in the United Kingdom. Each case farm was matched to 2–4 control farms of the same
production type and from the same veterinary practice to control for confounding.
A statistical power analysis was conducted to estimate the required sample size to detect
odds ratios of less than 0.54 or higher than 1.6 with a power of at least 80%, assuming indepen-
dence between observations and no matching, 10% risk factor prevalence in controls and a
95% confidence level for a 2-sided test. This resulted in a required sample size of 400 case
herds and 1600 control herds across the project countries. Thus, the aim was to recruit approx-
imately 100 case farms and 200–400 control farms in each country between 1st January and
31st December 2011. It was expected that the incidence of BNP cases during the data collection
period would vary between the countries.
Additionally, a case-control study at animal level was conducted, investigating animal-level
risk factors within BNP affected farms which has been published elsewhere [24]. The current
Herd-level risk factors BNP in a multi-country study
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study complements that previously published study by focussing on herd-level management
factors.
Definition of BNP case and matched control farms
A farm was classified as a case if it had at least one calf diagnosed with BNP in 2011. The case
definition for a BNP calf was: aged28 days with at least one of the following clinical signs of
haemorrhage: multiple skin haemorrhages, melaena, petechiae in mucus membranes, sudden
death, panmyelophthisis in bone marrow histology and/or thrombocytes below 150 x 109/litre
and leucocytes <5 x 109/litre.
A farm was classified as a matched control if it was of the same production type and served
by the same veterinary practice as the case farm and if it had never had a confirmed or sus-
pected (by either the veterinarian or the farmer) BNP calf.
Recruitment of farms
In each country veterinarians and farmers were encouraged to report suspected BNP cases to
the project team. Recruitment of farms was adapted to the local situation. In Germany, a
request to report suspected BNP cases together with a description of the study was published
in the German Veterinary Association’s journal (“Deutsches Tiera¨rzteblatt”) as well as in vari-
ous local farming publications. In the Netherlands, BNP cases were reported by farmers and
veterinarians as part of routine national surveillance. Additionally, the likelihood of reporting
was further increased by announcements in the local farming press and veterinary journals. In
Belgium, cases were also recruited as part of routine surveillance conducted by Ghent Univer-
sity and Animal Health Care Flanders (DGZ; Dierengezondheidszorg Vlaanderen), with farm-
ers and veterinarians informed via a website and encouraged to report suspect calves.
Furthermore, during the study several articles were published in farming journals to increase
the awareness of farmers and thereby likelihood of reporting. In France, the study was adver-
tised in the veterinary and farming press. For all countries, instructions and questionnaires
were available in local language for download via a website, and veterinarians were able to con-
tact the project team directly.
In each country, farms that reported suspected BNP cases were visited by a veterinarian
(either a local or a project veterinarian) and whole blood samples were collected from calves
suspected to be affected. In Germany, all blood samples were sent to the laboratory of the Lud-
wig Maximilian University (LMU) Munich Clinic for Ruminants. Carcasses of suspected cases
were sent to the locally responsible government animal health centres within Germany and the
post-mortem examination reports were sent to the project team at the LMU Munich. In the
Netherlands, all blood samples and carcasses were sent to GD Animal Health in Deventer. In
France, veterinarians involved in the on-farm data collection analysed the blood samples in
their own laboratory if possible, or in a human diagnostic laboratory. Gross-pathological signs
were recorded during the post-mortem examination by these veterinarians and bone-marrow
samples stored in formaldehyde were sent to Oniris for histological analysis. In Belgium, blood
samples from BNP suspected calves were examined in the laboratory of Ghent University,
Department of Internal Diseases of Large Animals, and carcasses were sent to DGZ for nec-
ropsy. Post mortem reports were sent to the project office. A bone marrow sample was sent to
the Department of Pathology at the Veterinary Faculty for final diagnosis of BNP.
If a BNP suspected calf was confirmed to have BNP based on the criteria described above,
the farm was classified as a ‘case-farm’ and visited for a detailed interview. The approach to
control farm selection varied by country. In Germany, the veterinarian reporting the BNP case
was asked to provide the contact details of six of their clients who had never had a suspected or
Herd-level risk factors BNP in a multi-country study
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confirmed BNP calf on their farm. From these six farms, four were selected randomly. In the
Netherlands, 10 herds of similar type and from the same veterinary practice were ranked by
distance to the case herds and contacted by the investigators for willingness to participate in
the study, starting with the first herd on the list and continuing until four control herds were
recruited. In Belgium and France, the veterinarian for each case farm was asked to provide
contact details of four of their clients with farms of the same management type.
Data collection
The data for this study was collected by structured interviews using a questionnaire. Given the
lack of knowledge of likely risk factors, apart from feeding of colostrum from PregSure vacci-
nated dams, the questionnaire covered a wide range of potential risk factors, including general
management practices, colostrum and milk feeding practices, vaccine and medicine use, and
BVD control measures (Table 1). Details of the clinical picture, such as of the number of calves
affected by BNP in previous years, were requested. A copy of the questionnaire is provided in
the supplementary material (S1 File). The questionnaire used in the case-control study con-
sisted of two parts: The first part asked about herd-level management information (the focus
of the current study) and the second part asked about the detailed history of affected calves
and chosen control calves (the focus of the previously published study [24]. Data used in the
present study were not analysed for the previous publication [24].
Because of the detailed information required from case farms on vaccinations and the man-
agement of the case and control calves, it was considered best for the veterinarian to complete
the questionnaire with the farmer during a face-to-face interview in their local language. In
France and Germany, the local veterinarian was sent a copy of the translated questionnaire
and was asked to complete this with the farmer and return it to the project coordinators in
their respective country. After the questionnaires were obtained by the coordinators, the
answers were checked for plausibility and completeness and, if necessary, veterinarians were
contacted for clarification. In the Netherlands and Belgium, one project veterinarian visited all
case farms and completed the questionnaire together with the farmer. Each case farm inter-
view lasted 1.5 to 2 hours.
For control farms, less detailed information was required as there were no affected calves.
Thus these farmers were contacted by telephone and a time for a telephone interview was
arranged. Telephone interviews were carried out by the project coordinators in the respective
countries.
All data were entered into a centralised database via a web-based data-entry form developed
at Ghent University, Department of Reproduction, Obstetrics and Herd Health, using the
open source software LimeSurvey (http://www.limesurvey.org). Data were then exported first
to a Microsoft Excel spreadsheet for preliminary cleaning and then into the SAS for Windows
9.3 statistical software for coding, further cleaning and analysis.
Table 1. Risk factor groups included in study questionnaire of multi-country BNP case-control study.
Risk group Subjects
General farm management Production type, number of cattle, changes to herd size, production, other
species being held on the farm, rearing of young stock, purchase and selling
Colostrum and milk feeding
of calves
Detailed information on colostrum and milk feeding of calves within the first
two weeks of life
Vaccinations Vaccinations done routinely on the farm, detailed for age groups of cattle
Treatments Medical treatments applied routinely to cattle
BVD-related BVDV history on the farm, BVDV vaccinations in detail
https://doi.org/10.1371/journal.pone.0179878.t001
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Data analysis
The database table consisted of 1462 records. If case farms had several BNP calves the farm
was represented multiple times in the database table. Since for the present analysis only farm
information was relevant, therefore duplicate records, representing information on different
calves from the same farm, were deleted. If conflicting information had been entered for a
farm, paper records were consulted for clarification. Records of case farms without a matched
control farm and records with a high percentage of missing values were deleted from the analy-
sis dataset. This resulted in a subset of data for analysis comprising 1250 observations.
Categorical variables with small numbers of observations in some categories were aggre-
gated into a smaller number of categories based on epidemiologically and biologically sensible
criteria. For the variable ‘Feeding colostrum from the calf’s own dam’ the category ‘always’ was
compared with the combined responses ‘sometimes’ and ‘never’. For the other variables, the
responses ‘always’ and ‘sometimes’ were combined and compared with ‘never’. Continuous
variables were assessed for normality using quantile-quantile plots. They were also inspected
for linearity using scatterplots and in the case of a non-linear relationship between the predic-
tor variable and the case/control status, the predictor variable was categorised using quartiles.
Variables were categorised into five different risk factor groups, representing variables
about general herd management, colostrum and milk feeding variables, vaccinations, treat-
ments and BVD-related variables (Table 1).
The following variables were created based on information from the original questionnaire
responses: vaccination on farm (i.e. whether any age-group was vaccinated), medication used
on farm (whether any age-group was treated), BVDV-vaccine used (whether any BVDV vac-
cine had been used) and variables for each brand of BVDV-vaccine, which were mentioned in
the questionnaires (PregSure, Bovilis BVD (MSD Animal Health), Bovidec BVD (Novartis
Animal Health), Mucosiffa/Vacoviron (Merial), Mucobovin (Merial) and Rispoval-BVD (Pfi-
zer Animal Health) [whether this brand had been used on any age-group at any time, either
currently or in the past]). Additionally, the variable ‘BVD vaccination’ was created to distin-
guish between farms that had used PregSure (and possibly other BVDV vaccines) at any time
in the past, those that had only used other BVDV vaccines and farms that had not used any
BVDV vaccines. The variables based on the questions ‘was the herd BVD free?’ and ‘on what
basis was BVD freedom determined?’ were not deemed to be risk factors for the occurrence of
BNP and were therefore omitted from the analysis.
The analysis was conducted in three steps: first a descriptive analysis; second, a univariable
analysis to assess the statistical significance of relationships between each putative risk factors
and the occurrence of BNP and third, a multivariable analysis to identify the most important
risk factors, controlling for confounding and testing biologically plausible interactions. In the
univariable analysis, to assess the effect of matching, an unmatched and a matched analysis
was conducted and results compared between the two. The unmatched analysis was performed
using Mann-Whitney U tests for continuous variables and for categorical variables odds ratios
were estimated using cross-tabulations with statistical significance determined using chi-
squared tests. The matched analysis used conditional logistic regression analysis to estimate
odds ratios for each variable with statistical significance being assessed using the Wald statistic.
The crude odds ratios obtained in the unmatched analysis were mostly closer to 1 than those
obtained in the conditional logistic regression analysis, indicating that matching had a positive
effect [25]. The multivariable analysis was also conducted in two steps. The first step involved
separate multivariable analyses for the five different risk factor groups (see Table 1). Variables
that were statistically significant in each of the individual risk-factor group analyses were then
included in the second step in an overall multivariable analysis. The multivariable analysis
Herd-level risk factors BNP in a multi-country study
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within each of the risk-factor groups included all variables within the group that had univari-
able p-values of< 0.20. If a variable was close to uniformity it was omitted from the multivari-
able analysis. Conditional logistic regression was used with backward stepwise variable
selection based on the likelihood-ratio statistic with a p-value of< 0.05 for entry and> 0.1 for
removal. To assess collinearity between variables, pair-wise associations were examined using
polychoric correlations. If two variables were highly correlated (r> 0.8) only one was offered
to the modelling algorithm, chosen based on biological reasoning or a lower p-value.
For the final model of the analysis across risk factor groups, first-order-interactions
between the significant main effect variables were assessed for their statistical significance.
Results are presented as odds ratios together with their 95% confidence intervals. All analyses
were conducted using SAS for Windows version 9.3 (SAS Institute, Cary, North Carolina,
USA).
Results
Descriptive results
In total, 212 farm records had to be omitted from the analysis due to duplication, incomplete
data or not being matched with a case or control farm. Thus, 1250 farm records remained in
the final database, of which 363 were case farms and 887 were control farms. Belgium contrib-
uted 70 case and 160 control farms, France 116 cases and 297 controls, Germany 77 cases and
203 controls and The Netherlands 100 cases and 227 controls. In total, there were 812 dairy
farms, 228 beef farms and 210 mixed farms. These were not evenly distributed between the
countries (Table 2).
The types of BVD vaccine used on case and control farms are shown in Table 3. More than
half of the control farms had not used any BVD vaccine, compared with only 7% of the case
farms. More than 85% of the case farms had used the BVD vaccine PregSure, compared with
22% of the control farms. Also 22% of the control farms only used other BVD vaccines, i.e. not
PregSure, compared with only 5% of the case farms.
Univariable analysis
Results of univariable analyses for each of the different risk factor groups are presented in S1–
S8 Tables. In the risk factor group ‘General farm management’ the total number of cattle on
the farm differed significantly between case and control farms, with a median of 150 cattle on
case farms and 130 cattle on control farms (p = 0.012; S1 Table). The number of lactating and
dry cows being held on the farm differed between case and control farms (median on case
farms 70 cows and median on control farms 60.5 cows, p = 0.010). In dairy farms the median
305 day lactation production was 8500 kg on case farms and 8300 kg on control farms
Table 2. Production type of farms included in multi-country BNP case control study.
Country Case-control status Dairy farms Beef farms Mixed farms
Belgium Case 33 17 20
Control 74 54 32
France Case 48 36 32
Control 139 110 48
Germany Case 63 2 12
Control 136 9 58
The Netherlands Case 96 0 4
Control 223 0 4
https://doi.org/10.1371/journal.pone.0179878.t002
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(p<0.001). In the risk factor group ‘Colostrum and milk feeding’ (S2 Table) calves on control
farms were more frequently allowed to suckle ad libitum at their first feeding than on case
farms (79% vs. 61%; p = 0.034). There were several differences between case and control farms
regarding the source of colostrum. Amongst case farms, a lower proportion of calves obtained
always the colostrum from their own dams than on control farms (p = 0.007). Feeding pooled
colostrum from dams of the own farm was sometimes practised on 15% of the case farms and
only on 8% of the control farms (p<0.001). Also colostrum substitutes without IgG were used
more frequently on case farms than on control farms, although their use was limited (3% vs.
1%; p = 0.005). After the colostrum phase, case farms more frequently used milk powder (51%
vs. 44%; p = 0.015), while control farms more frequently used bulk milk (48% vs. 40%;
p<0.001). In the risk factor group ‘Vaccinations’ (S3–S6 Tables) the variables were analysed
individually for each age group as well as at the entire herd level. There were significant differ-
ences in the use of vaccinations against BVD, IBR and BTV for each of the age groups and at
whole herd level, with case farms using these vaccinations more frequently than control farms
(p<0.001 for BVD; p<0.006 for IBR; p<0.002 for BTV). At entire herd level, vaccination
against BRSV was also used more frequently on case farms than control farms (p = 0.035).
Vaccinations against Trichophyton species were used in a small percentage of farms, but sig-
nificantly more often on case than control farms (p = 0.045). Different routine treatments (S7
Table) were also used slightly more frequently on case than control farms (sulfonamides: 8%
vs. 4%, p = 0.014; vitamin E/selenium: 19% vs. 14%, p = 0.012 and pour-on insecticides: 58%
vs. 52%, p = 0.023). Regarding the ‘BVDV-related’ risk factor group (S8 Table) several variables
differed significantly between case and control farms. Case herds had been free of BVD in the
previous 12 months less frequently than control herds (43% vs. 50%; p = 0.031). A higher pro-
portion of case farms had previously identified a persistently infected BVD animal (40% vs.
21%; p<0.001), and case farms more often had a BVD vaccination programme in place than
on control farms (82% vs. 41%; p<0.001). On case farms, the most frequently cited reason for
starting these vaccination programmes was an existing BVD problem (60%), while only 34%
of the control farms with a BVD vaccination programme cited this reason. At the time of the
interview, 59% of case farms were still vaccinating against BVDV compared with only 33% of
control farms (p<0.001). The case farms had more frequently used another BVD-vaccine in
the past than the one they used at the time of the interview (84% vs. 33% of the control farms;
p<0.001). Of the 337 (93%) case farms that had been using BVD vaccines, 92% used PregSure,
36% Bovilis, 10% Bovidec and 31% Rispoval BVD. Of the 416 (47%) control farms that had
been using BVD vaccines, the corresponding percentages were 43%, 33%, 8% and 40%, respec-
tively (p<0.001). Only 17% of the case farms used live attenuated BVD vaccines (Mucosiffa or
Vaccoviron), compared with 26% of control farms (p = 0.005). Combining the use of the dif-
ferent vaccines into the variable ‘BVD vaccination’, only 7% of the case farms did not use any
BVD vaccine, 88% used PregSure (with or without other BVD vaccines) and 5% used only
Table 3. Distribution of case and control farms using different BVDV vaccines in multi-country BNP
study (n = 1165).
BVD vaccination Case farms
(n = 351)
Control farms (n = 814)
No BVD vaccination 25 (7.1%) 454 (55.8%)
PregSure only 90 (25.6%) 28 (3.4%)
PregSure together with other BVD vaccines 219 (62.4%) 149 (18.3%)
Only other BVD vaccines, but no PregSure 17 (4.8) 183 (22.5%)
https://doi.org/10.1371/journal.pone.0179878.t003
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vaccines other than PregSure. For the control farms, these percentages were 56%, 22% and
22% respectively (p<0.001).
Multivariable analysis
Results of multivariable analyses for each of the five risk factor groups are shown in Table 4. From
the risk factor group ‘General farm management’ the variables ‘increase in dairy herd size’ and
‘average 305 day lactation production’ only applied to dairy farms, while the variable ‘increase
in beef herd size’ only applied to beef herds. A multivariable analysis excluding these variables
resulted in the retention of only the variable ‘total number of cattle’ (p = 0.010; Table 4). From the
risk factor group ‘Colostrum and milk feeding’, the variables ‘calves allowed to suckle ad lib’ and
the percentages of calves receiving colostrum from their own dam and from different dams were
excluded from multivariable analysis, as these parameters had a high percentage of missing values.
Table 4. Results of multivariable conditional logistic regression analysis for each of five risk factor groups for a multi-country BNP case-control
study.
Risk factor group (n) Variable Variable category Adjusted odds
ratio
95% confidence
intervals
Wald test p
value
General farm management
(1239)
Total number of cattle 1.001 1.000–1.003 0.0099
Colostrum and milk feeding
(1195)
Colostrum from own dam Always 0.640 0.456–0.899 0.0101
Sometimes / Never 1.000
Pooled colostrum from same
farm
Always / Sometimes 3.035 1.885–4.885 <0.0001
Never 1.000
Colostrum substitute without
IgG
Always / Sometimes 6.597 1.761–24.705 0.0051
Never 1.000
Colostrum substitute with IgG Always / Sometimes 2.132 1.040–4.373 0.0388
Never 1.000
Bulk milk feeding Yes 0.550 0.397–0.761 0.0003
No 1.000
Vaccinations (1250) BVD vaccination used by farm Yes 4.619 3.313–6.439 <0.0001
No 1.000
BTV vaccination used by farm Yes 1.454 1.049–2.014 0.0245
No 1.000
Treatments (1250) Sulfonamides used by farm Yes 2.032 1.098–3.752 0.0240
No 1.000
Suppl. Vitamin E and selenium Yes 1.520 1.048–2.204 0.0273
No 1.000
Insect repellent pour on used by
farm
Yes 1.336 1.009–1.769 0.0433
No
BVDV related (1087) BVD vaccination No BVD vaccination 1.000 <0.0001
PregSure useda 110.379 38.054–264.784
Other BVD vaccines
usedb
1.947 0.826–4.591
a PregSure vaccine used alone or other BVD vaccines as well
b Other BVD-vaccines used, not PregSure
https://doi.org/10.1371/journal.pone.0179878.t004
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Of the eight variables included in multivariable analysis, five variables remained in the final
model of this risk factor group (colostrum from own dam, p = 0.010; pooled colostrum from
same farm, p<0.001; colostrum substitute without IgG, p = 0,005; colostrum substitute with
IgG, p = 0.039; bulk milk feeding, p<0.001; Table 4). In the risk factor group ‘Vaccination’ the
herd-aggregated, and not the age-specific, variables were used because of strong correlations
between specific vaccinations for the three age-groups. Only two variables remained in the final
model for this risk factor group (vaccination against BVD, p<0.001 and vaccination against
BTV, p = 0.025; Table 4). Three variables from the risk factor group ‘Treatments’ remained in
the model (regular use of sulphonamides, p = 0.024, vitamin E/selenium, p = 0.027 and pour-on
insecticides, p = 0.043; Table 4). Within the risk factor group ‘BVDV related variables’ several
variables were correlated with each other. The variable ‘reason for starting a BVD vaccination
programme’ was excluded from the multivariable analysis, as it would have limited the dataset to
those farms that had a BVD vaccination programme in place. Only the variable ‘BVD vaccina-
tion’ was found to be significantly associated with the case-control status (Table 4).
All variables retained in the individual risk factor group models were examined for correla-
tions and then included in the combined multivariable analysis. A polychoric correlation coeffi-
cient of> 0.8 was found between the variable ‘BVD vaccination’ (BVD vaccine used, PregSure
used, other BVD vaccine used) from the risk factor group ‘BVD related variables’ and ‘BVD vacci-
nation used on farm’ (yes/no) from the risk factor group ‘Vaccinations’. The latter variable was
omitted, because it contained less information than the former. The results for the final model are
shown in Table 5. Three variables were retained: BVD vaccination, the use of colostrum from the
calf’s own dam (always versus sometimes/never), and the use of pooled colostrum from the same
farm (sometimes versus never). The use of PregSure had the highest odds ratio. A case farm had
107 times the odds (95% CI: 41.06 to 280.13) of using PregSure vaccine (on its own or together
with other BVD vaccines) rather than no BVD vaccination at all compared with a control farm,
adjusting for colostrum feeding practices. Case farms had 1.98 times the odds (95% CI: 1.13–3.42)
of always having used the colostrum from the calf’s dam rather than sometimes compared with
controls, adjusting for the use of BVD vaccines and the use of pooled colostrum. Also, case farms
had 4.1 times the odds (95% CI: 1.92–8.75) of sometimes having used pooled colostrum rather
than never, compared with control farms, adjusting for the use of BVD vaccines and using colos-
trum from the own dam. No statistically significant two-way interactions were identified.
Discussion
At the inception of this study, only limited information regarding the aetiology of BNP was
available. It had been hypothesised that BVD vaccines in general, or one in particular (Preg-
Sure) could play an important role [17, 19, 26]. It had also been reported that the disease was
Table 5. Results of the final multivariable conditional model using the variables of the five individual risk groups within a multi-country BNP study
(n = 1135).
Variable Variable category Adjusted odds ratio 95% confidence intervals Wald test p value
BVD vaccination No BVD vaccination 1.000 <0.0001
PregSure useda 107.246 41.059–280.127
Other BVD vaccines usedb 1.671 0.639–4.029
Colostrum from own dam Always used 1.976 1.131–3.421 0.0165
Sometimes/Never used 1.000
Pooled colostrum from own farm Always / Sometimes used 4.095 1.918–8.746 0.0003
Never 1.000
a PregSure vaccine used alone or other BVD vaccines as well
b Other BVD-vaccines used, not PregSure
https://doi.org/10.1371/journal.pone.0179878.t005
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associated with feeding colostrum from specific cows to newborn calves [1, 20]. To obtain an
understanding of the underlying causal web, the current study investigated a wide variety of
potential risk factors ranging from general herd management and vaccinations to feeding of
animals, especially calves. By including cattle farms in four countries, a variety of husbandry
and production systems were represented in the study. Therefore, the results obtained in the
present study are not limited to one region or one specific management system, but instead
apply across a range of systems. Furthermore, including four countries increased the likeli-
hood of obtaining sufficient cases from different production systems, given that BNP is quite a
rare disease. Prior to this study, only two smaller-scale case-control studies had been con-
ducted [17, 19]. Both studies reported a statistically significant association between the use of
PregSure and the occurrence of BNP. However, although PregSure had been used on thou-
sands of cattle farms in Europe, only about 6000 BNP cases have been reported in Europe [10].
This provides strong indications that in addition to PregSure vaccination other component
causes must be required which together form a sufficient cause that will result in BNP. Farm
characteristics and herd management factors had to be considered amongst these, but the
studies conducted so far had insufficient statistical power and represented insufficient varia-
tion in production systems to exclude the existence of such component causes. The current
study was designed to fulfil that knowledge gap. It was not possible to recruit the target num-
ber of 100 case farms and up to 400 control farms for each country during the one-year study
period due to limited case reporting in some countries. But the study still generated a database
with 363 case and 887 control farms suitable for analysis, thereby providing sufficient statistical
power to detect smaller effect sizes and representing a broader spectrum of cattle farming sys-
tems than any of the previous studies.
The case definitions used in each of the countries before the beginning of the study differed
slightly with regard to blood value thresholds or pathological findings. For the present study,
we used the same criteria across the four study countries. A calf was only classified as a BNP
case if it showed clinical signs and if panmyelophthisis was found in bone marrow histology
and/or if thrombocytopenia (values below 150 x 109/litre) and leukocytopenia (values below
<5 x 109/litre) were present. Pardon et al. [21] used different cut-off values of<100 x 109/litre
thrombocytes and<3 x 109/litre leucocytes, while Friedrich et al. [12] used values of< 200 x
109/litre thrombocytes and<4 x 109/litre leucocytes. The cut-off values chosen in the present
study were more stringent than the officially used ones, which varied across the study coun-
tries. Therefore, we are confident that case farms did not include any false positives. Recruit-
ment of control farms was based on the absence of clinical cases according to veterinarians’
and farmers’ recollection. We cannot completely exclude the possibility that some of the con-
trol farms were false negatives. If a significant number of control farms had been misclassified
this would have resulted in the effect sizes of the risk factors to have been underestimated. But
this is unlikely to have been the case due to the pathognomonic clinical signs of BNP. We took
particular care to ensure that control farms were highly likely to be unaffected: first the local
veterinarians had to confirm that they had never seen cases on these farms and second the
farm managers had to confirm that they had not had calves with clinical signs in the past.
Thus, if some control farms were still misclassified, it at most would be a very small percentage
of control farms and therefore unlikely to result in any meaningful bias of the effect estimates.
The possibility of bias resulting from different approaches to questionnaire administration
on case farms in the four countries cannot be excluded. In the Netherlands and Belgium, one
project veterinarian visited each of the case farms, maximising consistency of data collection.
In Germany and France, local veterinarians visited the case farms, hence potentially introduc-
ing potential bias as different individuals were involved in questionnaire administration. Fur-
thermore, the questionnaire was extensive and focused on different themes such as general
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farm management, vaccinations and milk feeding of calves. We attempted to reduce bias by
phrasing very precise questions, and whenever possible using records kept by farmers and vet-
erinarians and by checking for potential errors and misinterpretations once the questionnaires
had been returned to the country project centres. If there were any indications of such errors,
the local veterinarian and/or farmer were phoned for clarification. Furthermore, some ques-
tions were repeated in different ways in different sections of the questionnaire to provide an
internal cross-check and to help minimise recall bias. Additionally, farm managers of case
farms were interviewed within a period of 2–10 weeks of the case being diagnosed to further
minimise recall bias. Data collection on control farms offered less potential for heterogeneity
in information bias between countries, as all interviews were conducted by telephone in all
four countries. It is possible that face-to-face interviews have resulted in better data quality
than telephone interviews, thereby causing differential information bias between case and con-
trol farms. However, as the questions used for comparison between case and control farms
were all about general herd and calf management, this bias was considered negligible.
Further actions for reducing potential bias were taken at the analysis level. Data collected
on BVDV related issues were cross-checked and combined into a reduced set of new variables,
thus providing more reliable information and resulting in less multicollinearity between the
variables. Data collected for different age groups were analysed separately as well as aggregated
at the whole herd level, as the answers were highly collinear between the age groups.
In the final conditional logistic regression model, only three variables were significant:
BVDV vaccination, feeding of colostrum from calf’s own dam, and feeding of pooled colos-
trum. The variable ‘BVD vaccination’ incorporated vaccination information for all age groups
and also the type of vaccine used (no BVD vaccination, PregSure used with or without other
BVD vaccines, and other BVD vaccines used except PregSure). This variable had the largest
effect size in the multivariable analysis. Of all the risk factors, the highest odds ratio was for
using PregSure vaccine either alone or in combination with other BVDV vaccines. The associ-
ation between the use of PregSure and case-control status is consistent with results of previous
case-control studies, which reported odds ratios of 40.8 and 1292 for the use of PregSure [17,
19] and of other studies that examined the pathogenesis of BNP [13, 21–23, 27–30]. This factor
was also found to be significantly associated with the occurrence of BNP in our analysis at ani-
mal level [24]. This finding is supported by the absence of BNP reports from Switzerland, Den-
mark and Austria, where no BVD vaccination is allowed.
Another risk factor retained in the final multivariable model was the use of colostrum from
the calf’s own dam. The involvement of colostrum in the development of BNP has already
been confirmed in experimental studies [1, 20]. In our study, case farms had higher odds than
control farms of always (rather than only sometimes) using colostrum from the calf’s own
dam. Colostrum is important for a calf’s health and development [31–33] and it is generally
recommended to use colostrum from the dam or from other dams on the same farm, in order
to confer farm-specific immunity [34]. Most farmers in this study used colostrum from the
calf’s own dam. If these cows had previously had a BNP-affected calf, then continuing to feed
this specific colostrum, even from subsequent lactations, posed a risk of further occurrences of
BNP, due to the potentially still occurring production of the specific antibodies.
The third risk factor was the use of pooled colostrum. Case farms had higher odds than con-
trol farms of using colostrum pooled from multiple cows from their own farm. This finding is
supported by experimental studies, in which calves were more frequently and more severely
affected if given pooled colostrum from BNP cows rather than colostrum from one individual
cow which previously had at least one BNP calf [35, 36]. In previous farm-level case-control
studies for BNP this variable was either not included in questionnaires [19, 26] or was statisti-
cally also significant [17]. In our previously published study about calf-level factors associated
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with BNP, pooled colostrum was also found to be a risk factor for the occurrence of BNP [24].
The likely reason for an increased risk associated with using pooled colostrum is the mixing of
different alloantibody specificities included in the colostra of different cows and thus the
increased risk of including at least one colostrum source with antibodies in it that are able to
result BNP in the calf [35, 36].
Given the study had sufficient statistical power to identify risk factors with relatively small
odds ratios (OR1.6) and it representing a variety of cattle production systems in European
countries, it can be concluded with some confidence that farm characteristics and herd man-
agement factors, other than PregSure vaccination of the dam and colostrum usage, are unlikely
to have an important role in the causation of BNP. This leads to the conclusion that factors
other than those investigated are component causes that together with PregSure vaccination of
the dam and colostrum feeding form a sufficient cause for the occurrence of BNP in a calf.
Considering the very low incidence of the disease despite widespread use of PregSure [23], it is
likely that genetic factors are important. Given that the study included farms from four differ-
ent countries with a variety of breeds, the genetic predisposition of cows and/or calves must
occur across different cattle breeds. Different researchers have suggested that the expression of
MHC class I [29, 30] or other candidate proteins [37, 38] may play a role in BNP pathogenesis.
This current study conducted at herd level provides further evidence for a strong associa-
tion at farm level between the occurrence of BNP and the use of PregSure vaccine in cows, as
well as of the risk associated with either feeding colostrum from the calf’s dam or of pooled
colostrum. It can also be concluded with a fairly high degree of confidence that no other farm
characteristic or herd management factor studies here are risk factors for BNP. But given that
BNP incidence has been very low in the study countries, despite the two identified exposures
applying to very large numbers of calves in Europe, other important component causes which
together represent a sufficient cause of BNP still need to be identified. The genetic predisposi-
tion of the dams and/or calves is likely to be one such factor [39].
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